题名

Neuroimaging in Major Depressive Disorder: An Updated Review

并列篇名

重鬱症的神經造影：最新回顧

DOI

10.29478/TJP.200903.0003

作者

李俊德(Chun-Te Lee)；謝明鴻(Ming-Hong Hsieh)；陳錦宏(Chin-Hung Chen)；賴德仁(Te-Jen Lai)

关键词

重鬱症 ； 憂鬱 ； 神經造影 ； major depressive disorder ； depression ； neuroimaging

期刊名称

台灣精神醫學

卷期/出版年月

23卷1期（2009 / 03 / 01）

页次

14 - 29

内容语文

英文
中文摘要

背景：重鬱症（重度憂鬱症）是一種常見且會導致失能的精神疾病，它是一種複雜的疾病，在病理生理學、診斷及治療上存在顯著的異質性。目前，神經造影對於重鬱症的腦部結構及腦部功能已可提供新的觀點與了解。方法：我們使用電腦醫療目錄(Medline)搜尋，以「重鬱症」合併「神經造影」或「腦造影」為主詞加以搜尋2008年5月15日以前已出版的文獻，再從這些文獻搜尋相關的資訊。結果：在重鬱症的神經造影研究上，最一致的發現為大腦前面區域呈現異常，尤其是在額區、扣帶區及邊緣區，這些區域發現：高訊號白質出現的機率增加、白質的完整性出現缺損、膠質細胞的密度降低、大腦血流降低與葡萄糖代謝降低。所以，從諸多神經造影與其他生物學的發現，足可證實重鬱症是一種大腦疾病。而重鬱症在神經造影的局部異常發現，也可應用於臨床診斷與治療評估。對於老年憂鬱症的神經造影，發現存在較多的皮質下缺血性的所謂血管性憂鬱症。對於重鬱症與雙極性疾患的神經造影比較，兩者所影響的腦部區域及臉部表情的神經傳導過程皆不同。對於藥物治療與認知行為治療的神經造影比較，其治療後的神經造影改變皆不同，兩種治療方式雖然影響到相同的腦部局部位置，但是卻以不同的方式呈現。結論：重鬱症的神經造影發現能夠提供重鬱症在病理生理學、診斷及治療上獲得更完整的了解，俾利於提升重鬱症之照護品質。
英文摘要

Background: Major depressive disorder (MDD) is one of the prevalent and disabling psychiatric disorders. MDD is a complex disorder with marked heterogeneity in pathophysiology, diagnosis, and treatment. Currently, neuroimaging has given new insights into the structure and function of the brain in individuals with major depression. Methods: We did a Medline search with key words ”major depressive disorder” combined with ”neuroimaging” or ”brain imaging” up to May 15, 2008. We reviewed all identified published articles. Results: The most consistent findings in the pathophysiology studies of MDD with neuroimaging are abnormalities in the anterior regions of the brain, especially frontal, limbic, and cingulate regions, which presenting with increased rate of white matter hyperintensities, defect of white matter integrity, reduced glial cell density, reductions in cerebral flow or glucose metabolism. Thus, MDD is a brain disorder proved by neuroimaging and other biological findings. Findings of the regional abnormalities by neuroimaging may have clinical utility in both diagnosis and treatment of depression. Neuroimaging in geriatric depression found more subcortical ischemic vascular lesion, which is called vascular depression. It is noteworthy that the involved regions of brain and the neural processing of facial expressions may differ between MDD and bipolar disorder. Interestingly, there are clear regional change pattern differences across unique treatments, including medication and cognitive behavior therapy, affecting similar region but in different ways. Conclusion: We conclude that the findings of neuroimaging in individuals with MDD can help clinicians to get comprehensive understanding of depression in pathophysiology, diagnosis and treatment, and to ensure the quality of care in depression.
主题分类 醫藥衛生 > 社會醫學
参考文献
  1. Abou-Saleh MT,Al Subaili AR,Karim L,Prais V,Hamdi E(1999).Single photon emission tomography with 99mTc-HMPAO in flab patients with depression.J Affect Disord,55,115-123.
  2. Adolphs R(2002).Neural systems for recognizing emotion.Curr Opin Neurobiol,12,169-177.
  3. Aizenstein HJ,Nebes RD,Meltzer CC(2002).The relation of white matter hyperintensities to implicit learning in healthy older adults.Int J Geriatr Psychiatry,17,664-669.
  4. Alexopoulos GS(2005).Depression in the elderly.Lancet,365,1961-1970.
  5. Alexopoulos GS,Kiosses D,Choi S,Murphy CF,Lim KO(2002).Frontal white matter microstructure arid treatment response of late-life depression: a preliminary study.Am J Psychiatry,159,1929-1931.
  6. Alexopoulos GS,Meyers BS,Young RC,Combell S,Silbergsweig D,Charlson M(1997).Vascular depression hypothesis.Arch Gen Psychiatry,54,915-922.
  7. Altamura C,Maes M,Dai J,Meltzer HY(1995).Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression.Eur Neuropsychopharmacol,5,71-75.
  8. Anand A,Li Y,Wang Y(2005).Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study.Biol Psychiatry,57,1079-1088.
  9. Austin MP,Dougall N,Ross M(1992).Single photon emission tomography with Tc99m exametazime in major depression and the pattern of brain activity underlying the psychotic and neurotic continuum.J Affect Disord,26,31-44.
  10. Bae JN,MacFall JR,Krishnan KR,Payne ME,Steffens DC,Taylor WD(2006).Dorsolateral prefrontal cortex and anterior cingulated cortex white matter alterations in late-life depression.Biol Psychiatry,60,1356-1363.
  11. Baxter Jr LR,Schwartz JM,Phelps ME(1989).Reduction of prefrontal cortex glucose metabolism common to three types of depression.Arch Gen Psychiatry,46,243-250.
  12. Beaulieu C(2002).The basis of anisotropic water diffusion in the nervous system-a technical review.NMR Biomed,15,435-455.
  13. Beaulieu C,Allen PS(1994).Water diffusion in the giant axon of the squid: implications for diffusion- weighted MR imaging of the human brain.Magn Reson Med,32,579-583.
  14. Bench CJ,Friston KJ,Brown RG,Scott LC,Frackowiak RS,Dolan RJ(1992).The anatomy of melancholia-focal abnormalities of cerebral blood flow in major depression.Psychol Med,22,607-615.
  15. Benes FM,Todtenkopf MS,Logiotatos P,Williams M(2000).Glutamate decarboxylase (65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain.J Chem Neuroanat,20,259-269.
  16. Boone KB,Miller BL,Lesser IM(1992).Neuropsychological correlates of white-matter lesions in healthy elderly subjects.threshold effect: Arch Neural,49,549-554.
  17. Bremner JD,Narayan M,Anderson ER,Staib LH,Miller HL,Charney DS(2000).Hippocampal volume reduction in major depression.Am J Psychiatry,57,115-118.
  18. Bremner JD,Vythilingam M,Vermetten E(2002).Reduced volume of orbitofrontal cortex in major depression.Biol Psychiatry,51,273-279.
  19. Buchsbaum MS,Wu J,Siegel BV(1997).Effect of sertraline on regional metabolic rate in patients with affective disorder.Biol Psychiatry,41,15-22.
  20. Burns A,Jacoby R,Levy R(1990).Psychiatric phenomena in Alzheimer's disease.Br J Psychiatry,157,81-86.
  21. Catafau AM,Perez V,Gironell A(2001).SPECT mapping of cerebral activity changes induced by repetitive transcranial magnetic stimulation in depressed patients. A pilot study.Psychiatry Res,106,151-160.
  22. Coffey CE,Wilkinson WE,Parashos IA,Soady SA,Sullivan RJ,Patterson LJ(1992).Quantitative cerebral anatomy of the aging human brain: cross-sectional study using magnetic resonance imaging.Neurology,42,527-536.
  23. Cowen PJ(1991).Serotonin receptor sub-types: implications for psychopharmacology.Br J Psychiatry,159(12),7-14.
  24. Cummings JL(1992).Depression and Parkinson's disease: A review.Am J Psychiatry,149,443-454.
  25. Drevets WC(2000).Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression.Prog Brain Res,126,413-431.
  26. Drevets WC,Bogers W,Raichle ME(2002).Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism.Eur Neurospsychopharmacol,12,527-544.
  27. Drevets WC,Price JL,Simpson Jr JR.(1997).Subgenual prefrontal abnormalities in mood disorders.Nature,386,824-827.
  28. Drevets WC,Videen TO,Price JL,Preskorn SH,Carmichael ST,Raichle ME(1992).A functional anatomical study of unipolar depression.J Neurosci,12,3628-3641.
  29. Duman RS,Malberg JE(1998).Neural plasticity in the pathophysiology and treatment of depression.Neuropsychopharmacology,37,261.
  30. Figiel GS,Krishnan KRR,Doraiswamy PM,Rao VP,Nemeroff CB,Boyko OB(1991).Subcortical hyperintensities on brain magnetic resonance imaging: comparison between late age onset and early onset elderly depressed subjects.Neurobiol Aging,12,245-247.
  31. Fitzgerald PB,Brown TL,Daskalakis ZJ(2002).The application of transcranial magnetic stimulation in psychiatry and neurosciences research.Acta Psychiatr Scand,105,324-340.
  32. Folstein SE,Abbott MH,Chase GA,Jensen BA,Folstein MF(1983).The association of affective disorder with Huntington's disease in a case series and in families.Psychol Med,13,537-542.
  33. Frodl T,Meisenzahl E,Zetzsche T,Bottlelender R,Born C,Groll C(2005).Enlargement of the amygdala in patients with a first episode of major depression.Biol Psychiatry,51,708-714.
  34. Fu CHY,Williams SCR,Cleare AJ(2004).Attenuation of the neural response to sad faces in major depression by antidepressant treatment.Arch Gen Psychiatry,61,877-889.
  35. Goldapple K,Segal Z,Garson C(2004).Modulation of cortical-limbic pathways in major depression: treatment specific effects of cognitive behavioral therapy compared to paroxetine.Arch Gen Psychiatry,61,34-41.
  36. Greenwald BS,Kramer-Ginsberg E,Bogerts B,Ashtari M,Aupperle P,Wu H(1997).Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer's disease.Psychol Med,27,421-431.
  37. Hamidi M,Drevets WC,Price IL(2004).Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes.Biol Psychiatry,55,563-569.
  38. Hasler G,Neumeister A,van der Veen JW(2005).Normal prefrontal -aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.Biol Psychiatry,58,969-973.
  39. Hasler G,van der Veen JW,Tumonis T,Meyers N,Shen J, drevets WC(2007).Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determinated using proton magnetic resonance spectroscopy.Arch Gen Psychiatry,64,193-200.
  40. Haxby JV,Hoffman EA,Gobbini MI(2002).Human neural systems for face recognition and social communication.Biol Psychiatry,51,59-67.
  41. Henry ME,Schmidt ME,Matochik JA,Stoddard EP,Potter WZ(2001).The effects of ECT on brain glucose metabolism: a pilot FDG PET study.J ECT,17,33-40.
  42. Holsboer F,Lauer CJ,Schreiber W,Krieg JC(1995).Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders.Neuroendocrinology,62,340-347.
  43. Jorge RE,Robinson RG,Moser D,Tateno A,Crespo-Facorro B,Arndt S(2004).Major depression following traumatic brain injury.Arch Gen Psychiatry,61,42-50.
  44. Jorm AF,Anstey KJ,Christensen H(2005).MRI hyperintensities and depressive symptoms in a community sample of individuals 60-64 years old.Am J Psychiatry,162,699-705.
  45. Kapur S,Mann JJ(1992).Role of the dopaminergic system in depression.Biol Psychiatry,32,1-17.
  46. Kennedy SH,Evans KR,Kruger S(2001).Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.Am J Psychiatry,158,899-905.
  47. Kimura M,Shimoda K,Mori T(2002).Changes in regional cerebral blood flow on recovery from depression: comparison of vascular depression and non-vascular depression.Int Congress Series,1232,757-761.
  48. Klemm E,Danos P,Grunwald F,Kasper S,Moller HJ,Biersack HJ(1996).Temporal lobe dysfunction and correlation of regional cerebral blood flow abnor malities with psychopathology in schizophrenia and major depression: study with single photon emission computed tomography.Psychiatry Res Neuroimaging,68,1-10.
  49. Klimke A(1999).Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT.Psychiatry Res Neuroimaging,90,91-101.
  50. Krishnan KR,Taylor WD,McQuoid DR(2004).Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression.Biol Psychiatry,55,390-397.
  51. Lai TJ,Payne ME,Byrum CE,Steffens DC,Krishnan KRR(2000).Reduction in orbital frontal cortex volume in geriatric depression.Biol Psychiatry,48,971-975.
  52. Lampe IK,Hulshoff Pol HE,Janssen J,Schnack HG,Kahn RS,Heeren TJ(2003).Association of depression duration with reduction of global cerebral gray matter volume in female patients with recurrent major depressive disorder.Am J Psychiatry,160,2052-2054.
  53. Lawrence KS,Williams AM,Surguladze S(2004).Subcortical and Ventral prefrontal cortical neural responses to facial expressions patients with bipolar disorder and major disorder.Biol Psychiatry,55,578-587.
  54. Lee SH,Payne ME,Steffens DC(2003).Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression.Biol Psychiatry,54,529-533.
  55. Lennox BR,Jacob R,Calder AJ,Lupson V,Bullmore ET(2004).Behavioural and neurocognitive responses to sad facial affect are attenuated in patients with mania.Psychol Med,34,795-802.
  56. Lenze E,Sheline Y(1999).Absence of striatal volume differences between healthy depressed subjects and matched comparisons.Am J Psychiatry,156,1989-1991.
  57. Lesser IM,Mena I,Boone KB,Miller BL,Mehringer CM,WohI M(1994).Reduction of cerebral blood flow in older depressed patients.Arch Gen Psychiatry,51,677-686.
  58. Ma N,Li L,Shu N(2007).White matter abnormalities in first-episode, treatment-naïve young adults with major depressive disorder.Am J Psychiatry,164,823-826.
  59. Macs M,Dierckx K,Meltzer HY,Ingels M,Schotte C,Vandewoude M(1993).Regional cerebral blood flow in unipolar depression measured with 99m Tc-HMPAO single photon emission tomography: negative findings.Psychiatry Res,50,77-88.
  60. Malison PT,Price LH,Berman R,van Dyck CH,Pelton GH,Carpenter L(1998).Reduced brain serotonin transporter availability in major depression as measured by [123I]-2[beta]-carbomethoxy-3[beta]-(4-iodophenyl)tropane and single photon emission computed tomography.Biol Psychiatry,44,1090-1098.
  61. Manji EK,Quiroz JA,Sporn J(2003).Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.Biol Psychiatry,53,707-742.
  62. Martin DL,Rimvall K(1993).Regulation of -aminobutyric acid synthesis in the brain.J Neurochem,60,395-407.
  63. Martin DL,Tobin AJ,Martin DL(eds.),Olsen RW(eds.)(2000).GABA in the Nervous System: The View at Fifty Years.Philadelphia, Pa:Lippincott Williams & Wilkins.
  64. Mayberg H,Lewis PJ,Regenold W,Wagner HN(1994).Paralimbic hypoperfusion in unipolar depression.J Nucl Med,35,929-934.
  65. Mayberg HS,Brannan SK,Mahurin RK,Jerabek PA,Brickman JS,Tekell JL(1997).Cingulate function in depression: a potential predictor of treatment response.Neuroreport,8,1057-1061.
  66. Mayberg US(2003).Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimal treatment.Br Med Bull,65,193-207.
  67. Mervaata E,Fohr J,Kononen M,Valkonen-Korhonen M,Vainio P,Partanen K(2000).Quantitative MRI of the hippocampus and amygdala in severe depression.Psychol Med,30,117-125.
  68. Michael N,Erfurth A,Ohrmann P,Arolt V,Heindel W,Pfleiderer B(2003).Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression.Neuropsychopharmacology,28,720-725.
  69. Nahas Z,Teneback CC,Kozel A(2001).Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance.J Neuropsychiatry Clin Neurosci,13,459-470.
  70. Nauta WJ(1972).Neural associations of the frontal cortex.Acta Neurobiol Exp (Warsz),32,125-140.
  71. Nobuhara K,Okugawa G,Minami T(2004).Effects of electroconvulsive therapy on frontal white matter in late-life depression: a diffusion tensor imaging study.Neuropsychobiology,50,48-53.
  72. Peschina W,Conca A,Konig P(2001).Low frequency rTMS as an add on antidepressive strategy: heterogeneous impact on 99mTc-HMPAO and 18 FFDG uptake as measured simultaneously with the double isotope SPECT technique: pilot study.Nucl Med Commun,22,867-873.
  73. Petty F,Sherman AD(1984).Plasma GABA levels in psychiatric illness.J Affect Disord,6,131-138.
  74. Pfleiderer B,Michael N,Erfurth A(2003).Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients.Psychiatry Res,122,185-192.
  75. Phillips ML,Drevets WC,Rauch SL,Lane R(2003).Neurobiology of emotion perception.Biol Psychiatry,54,504-514.
  76. Price JL(1999).Prefrontal cortical networks related to visceral function and mood.Ann N Y Acad Sci,877,383-396.
  77. Raichlem E,Grubbr L,Gado NH,Eichling JO,Ter-Pogossian MM(1976).Correlation between regional cerebral blood flow and oxidative metabolism.Arch Neural,33,523-526.
  78. Rajkowska G,Miguel-Hidalgo JJ,Wei J,Dilley G,Pittman SD,Meltzer HY(1999).Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.Biol Psychiatry,45,1085-1098.
  79. Sackeim HA,Prohovnik I,Moeller JR(1990).Regional cerebral blood flow in mood disorders.Arch Gen Psychiatry,47,60-70.
  80. Sanacora G,Mason GF,Rothman DL(1999).Reduced cortical-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.Arch Gen Psychiatry,56,1043-1047.
  81. Sawrie SM,Martin RC,Knowlton R,Faught E,Gilliam F,Kuzniecky R(2001).Relationships among hippocampal volumetry, proton magnetic resonance spectroscopy, and verbal memory in temporal lobe epilepsy.Epilepsy,42,1403-1407.
  82. Seminowicz DA,Mayberg HS,McIntosh AR(2004).Limbic-frontal circuitry in major depression: a path modeling meta-analysis.Neuroimage,22,409-418.
  83. Sheline YI(2003).Neuroimaging studies of mood disorder effects on the brain.Biol Psychiatry,54,338-352.
  84. Sheline YI,Gado MH,Price JL(1998).Amygdala core nuclei volumes are decreased in recurrent major depression.Neuroreport,9,2023-2028.
  85. Simpson S,Baldwin RC,Jackson A,Burns AS(1998).Is subcortical disease associated with a poor response to antidepressants? neurological, neuropsychological, and neuroradiological findings in late-life depression.Psychol Med,28,1015-1026.
  86. Smith DJ,Cavanagh JTO(2005).The use of single photon emission computed tomography in depressive disorders.Nucl Med Commu,26,197-203.
  87. Soares JC,Mann JJ(1997).The anatomy of mood disorders: review of structural neuroimaging studies.Biol Psychiatry,41,86-106.
  88. Speer AM,Kimbrell TA,Wassennann EM(2000).Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients.Biol Psychiatry,48,1133-1141.
  89. Starkstein SE,Robinson RG(1989).Affective disorders and cerebral vascular disease.Br J Psychiatry,154,170-182.
  90. Steffens DC,Krishnan KR(1998).Structural neuroimaging and mood disorders: Recent findings, implications for classification, and future directions.Biol Psychiatry,43,705-712.
  91. Surguladze S,Brammer MJ,Keedwell P(2005).A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder.Biol Psychiatry,57,201-209.
  92. Taylor WD,MacFall JR,Payne ME(2005).Greater MRI lesion volumes in elderly depressed subjects than in control subjects.Psychiatry Res,139,1-7.
  93. Taylor WD,Steffens DV,McQuoid DR(2003).Smaller orbital frontal cortex volumes associated with functional disability in depressed elders.Biol Psychiatry,53,144-149.
  94. Teneback CC,Nahas Z,Speer AM(1999).Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS.J Neuropsychiatry Clin Neurosci,11,426-435.
  95. Tupler LA,Krishnan KR,McDonald WM,Dombeck CD,D''Souza S,Steffens DC(2002).Anatomic location and laterality of MRI signal hyperintensities in late-life depression.J Psychosom Res,53,665-676.
  96. Vasile RG,Schwartz RB,Garada B(1996).Focal cerebral diffusion defects demonstrated by 99m Tchexamethylpropyleneamine oxime SPECT in elderly depressed patients.Psychiatry Res: Neuroimaging,67,59-70.
  97. Videbech P(2000).PET measurements of brain glucose metabolism arid blood flow in major depressive disorder: a critical review.Acta Psychiat Scand,101,11-20.
  98. Videbech P,Ravnkilde B(2004).Hippocampal volume and depression: a meta-analysis of MRI studies.Am J Psychiatry,161,1957-1966.
print cancel